CD34 and neoplasm: The peptide shows stronger cytotoxicity against leukemic tumor cell lines (KG1-a and CCRF-CEM) than the normal cell lines (CD34+, HRECs and HACAT) [10], which indicates that Smp24 may be a potential ACP.